You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Divergent Effects in the Treatment of Hyperlipemia

I. ARNOLD SLOWE, MD; ANNE C. CARTER, MD; ELAINE B. FELDMAN, MD

Arch Intern Med. 1965;116(4):523-530.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THORP AND WARING demonstrated that clofibrate (Atromid S) lowered levels of serum and liver cholesterol in rats.1 Other studies suggested that a mixture of androsterone and clofibrate (Atromid) potentiated the lipid-lowering effect.2 The successful use of this mixture to decrease serum lipid concentration in patients with coronary sclerosis by Oliver in 19623 prompted the present study of the effects of clofibrate alone or with androsterone in patients with frank disorders of lipid metabolism. In the course of these investigations, published reports suggested that clofibrate alone was responsible for the lipid-lowering action of the mixture and that addition of androsterone produced no enhancement.4-8

Materials and Methods

The patients (Table 1) ranged in age from 10 to 72 years. They included four men, three women with hyperlipemia, a boy with idiopathic hyperlipemia, and a boy with glycogen-storage disease (glucose-6-phosphatase deficient). In five of seven families studied familial incidence of hyperlipemia was demonstrated. . . . [Full Text PDF of this Article]


Author Affiliations

BROOKLYN

From the Department of Medicine, State University of New York Downstate Medical Center and the Kings County Hospital, Brooklyn. Instructor, Department of Medicine (Dr. Slowe); Associate Professor, Department of Medicine (Dr. Carter); and Assistant Professor, Department of Medicine (Dr. Feldman).


Footnotes

Received for publication Sept 30, 1964; accepted March 24, 1965.

A preliminary report of these data was read before the New York regional meeting of the American College of Physicians, Jan 14, 1964.

Reprint requests to State University of New York Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203 (Dr. Carter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.